Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Model for predicting curative effect of hepatocellular carcinoma immunotherapy and construction method thereof

A technology for immunotherapy and hepatocellular carcinoma, applied in the field of clinical medicine

Active Publication Date: 2021-04-06
ZHEJIANG UNIV
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are currently no well-established models that can reliably predict patient response and prognosis to HCC immunotherapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Model for predicting curative effect of hepatocellular carcinoma immunotherapy and construction method thereof
  • Model for predicting curative effect of hepatocellular carcinoma immunotherapy and construction method thereof
  • Model for predicting curative effect of hepatocellular carcinoma immunotherapy and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0047] Tissue Microarray (TMA) Structural Five-Gene Model Evaluation

[0048] To evaluate the prognostic power of the 5-gene model, we performed immunohistochemistry (IHC) using a tissue microarray (Shanghai Xinchao Biotechnology Co., Ltd.) of cancer tissues from 90 HCC patients and measured integrated densitometric analysis. The primary antibodies used are listed in Table 1. IHC scores were independently assessed by three senior pathologists without knowledge of patient characteristics. IHC score calculation: including IHC score=[0.307×protein LDHA expression level]+[0.268×proteinPPAT expression level+[0.455×protein BFSP1 expression level]+[0.234×protein NROB1 expression level]+[0.109×protein PFKFB4 expression level] . Kaplan-Meier log-rank analysis was used to evaluate the difference in survival between the high and low IHC score groups.

[0049] Table 1. Antibody Information Sheet

[0050]

[0051] The protein expression levels of five genes LDHA, PPAT, BFSP1, NR0B1 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of clinical medicine, and relates to a model for predicting the curative effect of hepatocellular carcinoma immunotherapy based on 5 genes and a construction method thereof. The model for predicting the immunotherapy effect of hepatocellular carcinoma comprises five genes, namely lactic dehydrogenase A (LDHA), phosphatide phosphoramidate heterogeneous enzyme (PPAT), a bead fiber structural protein 1 (BFSP1), a nuclear receptor sub-fiber 0 group B member 1 (NR0B1) and 6-phosphatide-2-kinase / fructolase-2,6-diphosphatase 4 (PFPFB4). The invention also provides a construction method of the model for predicting the curative effect of hepatocellular carcinoma immunotherapy based on the 5 genes. Herein, the new immune microenvironment model based on 5 genes is established, so that the effect of a patient on HCC immunotherapy can be effectively predicted, and the 5 genes can be used as potential biomarkers to be clinically applied.

Description

technical field [0001] The invention belongs to the field of clinical medicine, and relates to a 5-gene-based model for predicting the therapeutic effect of hepatocellular carcinoma immunotherapy and a construction method thereof. Background technique [0002] Hepatocellular carcinoma (HCC) is a highly malignant cancer and the third leading cause of cancer-related death worldwide. The 5-year survival and overall survival were less than 12%. Most HCC patients develop from liver cirrhosis, chronic hepatitis virus infection, alcohol-related liver disease, nonalcoholic fatty liver disease, and drug-induced hepatitis. Since HCC is usually not diagnosed early, treatment is less effective. Therefore, the development of new diagnostic molecular markers is very important to improve the prognosis of patients. [0003] The immune microenvironment plays a key role in tumorigenesis and is associated with tumor progression and therapeutic efficacy. Systemic immunotherapy has shown eff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16B40/00G16B25/00G16H50/70G16H50/30G16H10/20G01N33/574
CPCG16B40/00G16B25/00G16H50/70G16H50/30G16H10/20G01N33/57438
Inventor 朱海红顾心雨陈智管俊
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com